Published in Biochem J on November 15, 1994
Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. World J Gastroenterol (2006) 1.39
Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes. Diabetes (2010) 1.18
Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation. Bioconjug Chem (2006) 1.10
Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins. Am J Physiol Gastrointest Liver Physiol (2010) 1.02
New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun (1998) 0.96
Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition study. Hypertension (2009) 0.93
Age-related changes in scavenger receptor-mediated endocytosis in rat liver sinusoidal endothelial cells. J Gerontol A Biol Sci Med Sci (2010) 0.82
Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice. FASEB J (2012) 0.82
Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors. J Lipid Res (2013) 0.80
FITC Conjugation Markedly Enhances Hepatic Clearance of N-Formyl Peptides. PLoS One (2016) 0.75
Efficient trace-labelling of proteins with iodine. Nature (1958) 23.16
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med (1989) 15.67
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A (1979) 11.19
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta (1972) 9.02
Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem (1966) 7.11
Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A (1976) 6.38
Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A (1980) 4.66
Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature (1990) 4.52
Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem (1975) 3.97
The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramol Struct (1980) 3.10
In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J Biol Chem (1983) 2.61
Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature (1990) 2.40
Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest (1991) 2.35
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 2.11
Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci U S A (1982) 2.04
Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells. J Cell Biol (1985) 1.88
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem (1991) 1.61
Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem (1993) 1.53
The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J Biol Chem (1993) 1.39
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39
Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes. Hepatology (1993) 0.86
In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats. J Lipid Res (1992) 0.84
In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J Biol Chem (1983) 2.61
The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol (1996) 2.34
Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ Res (2001) 1.91
Selective liver targeting of antivirals by recombinant chylomicrons--a new therapeutic approach to hepatitis B. Nat Med (1995) 1.77
Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation (2001) 1.77
Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology (1995) 1.69
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. J Lipid Res (2001) 1.43
Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J (2001) 1.31
Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo. J Biol Chem (2001) 1.30
In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells. Nucleic Acids Res (1997) 1.28
Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res (1997) 1.24
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem (1990) 1.24
Tissue distribution of factor VIII gene expression in vivo--a closer look. Thromb Haemost (2001) 1.24
Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol (2006) 1.22
Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells. J Biol Chem (1988) 1.21
Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J Biol Chem (1993) 1.19
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev (2001) 1.17
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. J Biol Chem (1988) 1.12
Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells. Eur J Biochem (1996) 1.11
Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood (2000) 1.09
Selective uptake of cholesteryl esters from apolipoprotein-E-free high-density lipoproteins by rat parenchymal cells in vivo is efficiently coupled to bile acid synthesis. Biochem J (1991) 1.09
In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells. J Biol Chem (1998) 1.08
Hepatic and extrahepatic scavenger receptors: function in relation to disease. Arterioscler Thromb Vasc Biol (2000) 1.06
The multiple roles of macrophage scavenger receptors (MSR) in vivo: resistance to atherosclerosis and susceptibility to infection in MSR knockout mice. J Atheroscler Thromb (1997) 1.04
Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucleic Acids Res (1991) 1.03
Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro. J Pharmacol Exp Ther (1996) 1.03
Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem (1996) 1.02
Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol (2009) 1.02
Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins. Biochem Biophys Res Commun (1992) 1.01
Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Thromb Res Suppl (1990) 1.01
Eicosanoid production by rat cerebral endothelial cells: stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. J Neuroimmunol (1995) 1.01
Hormone-induced changes in pyruvate kinase. Effects of glucagon and starvation. Eur J Biochem (1977) 0.99
Hepatic processing of the cholesteryl ester from low density lipoprotein in the rat. J Biol Chem (1986) 0.99
Scavenger receptor BI mediates the selective uptake of oxidized cholesterol esters by rat liver. J Biol Chem (1999) 0.99
Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem (1992) 0.99
The effect of Ca2+ and the trifluoperazine on the processing of human acetylated low density lipoprotein by non-parenchymal liver cells. FEBS Lett (1981) 0.99
Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor. J Med Chem (1995) 0.98
The effect of a water-soluble tris-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes. J Biol Chem (1985) 0.98
Binding of liver lipase to parenchymal and non-parenchymal rat liver cells. Biochem Biophys Res Commun (1978) 0.98
In vivo uptake of human and rat low density and high density lipoprotein by parenchymal and nonparenchymal cells from rat liver. Biochim Biophys Acta (1978) 0.97
Mechanism of glucagon stimulation of fructose-1,6-bisphosphatase in rat hepatocytes. Involvement of a low-Mr activator. FEBS Lett (1986) 0.96
New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun (1998) 0.96
Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta- very low density lipoprotein binding. J Biol Chem (1993) 0.95
Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis. J Biol Chem (2000) 0.95
Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation. Nucleic Acids Res (2000) 0.95
alpha3-galactosylated glycoproteins can bind to the hepatic asialoglycoprotein receptor. Eur J Biochem (2000) 0.94
Lymphocyte adhesion to brain capillary endothelial cells in vitro. J Neuroimmunol (1994) 0.92
Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. J Med Chem (1999) 0.92
In vivo catabolism of biologically modified LDL. Arteriosclerosis (1984) 0.92
Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res (2001) 0.92
A saturable, high-affinity binding site for human low density lipoprotein on freshly isolated rat hepatocytes. Biochim Biophys Acta (1982) 0.91
Scavenger receptor B1 (SR-B1) substrates inhibit the selective uptake of high-density-lipoprotein cholesteryl esters by rat parenchymal liver cells. Biochem J (1997) 0.91
Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cells. Biochim Biophys Acta (1988) 0.91
Specific targeting of high density lipoproteins to liver hepatocytes by incorporation of a tris-galactoside-terminated cholesterol derivative. J Biol Chem (1985) 0.90
Light- and immunoelectron microscopic visualization of in vivo endocytosis of low density lipoprotein by hepatocytes and Kupffer cells in rat liver. Lab Invest (1990) 0.89
Cellular localization of the receptor-dependent and receptor-independent uptake of human LDL in the liver of normal and 17 alpha-ethinyl estradiol-treated rats. FEBS Lett (1983) 0.89
Distribution of L- and M-type pyruvate kinase between parenchymal and Kupffer cells of rat liver. Biochim Biophys Acta (1972) 0.89
Analytical study of microsomes and isolated subcellular membranes from rat liver. IX. Nicotinamide adenine dinucleotide glycohydrolase: a plasma membrane enzyme prominently found in Kupffer cells. J Cell Biol (1985) 0.89
Visualization of the interaction of native and modified low density lipoproteins with isolated rat liver cells. Eur J Cell Biol (1985) 0.89
Increased selective uptake in vivo and in vitro of oxidized cholesteryl esters from high-density lipoprotein by rat liver parenchymal cells. Biochem J (1996) 0.89
Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice. Br J Cancer (1996) 0.89
Characterization of the chylomicron-remnant-recognition sites on parenchymal and Kupffer cells of rat liver. Selective inhibition of parenchymal cell recognition by lactoferrin. Eur J Biochem (1992) 0.89
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. J Biol Chem (1996) 0.88
Uptake and degradation of rat and human very low density (remnant) apolipoprotein by parenchymal and non-parenchymal rat liver cells. Biochim Biophys Acta (1980) 0.88
Cyclic nucleotide-, pyruvate- and hormone-induced changes in pyruvate kinase activity in isolated rat hepatocytes. Biochem Biophys Res Commun (1976) 0.88
Characterization in vitro of interaction of human apolipoprotein E-free high density lipoprotein with human hepatocytes. Arteriosclerosis (1990) 0.88
The influence of glucose I,6-diphosphate on the enzymatic activity of pyruvate kinase. Biochim Biophys Acta (1972) 0.87
Visualization of the interaction of native and modified lipoproteins with parenchymal, endothelial and Kupffer cells from human liver. Hepatology (1991) 0.86
Prolonged serum half-life of antineoplastic drugs by incorporation into the low density lipoprotein. Cancer Res (1990) 0.86
Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo. Biochem J (1999) 0.86
Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes. Hepatology (1993) 0.86
Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions. Biochem J (1996) 0.85
Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and Kupffer cells of the liver: evidence for scavenger receptor heterogeneity. Biochem Biophys Res Commun (1991) 0.85
In vivo and in vitro catabolism of native and biologically modified LDL. FEBS Lett (1984) 0.84
The role of scavenger receptor class A in the adhesion of cells is dependent on cell type and cellular activation state. Exp Cell Res (1999) 0.84
Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis. J Pharmacol Exp Ther (1999) 0.84
In vivo studies on the binding sites for lipoprotein (a) on parenchymal and non-parenchymal rat liver cells. FEBS Lett (1988) 0.84
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Circulation (1997) 0.84
In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats. J Lipid Res (1992) 0.84
Characterization of the interaction of acetylated LDL and oxidatively modified LDL with human liver parenchymal and Kupffer cells in culture. Arterioscler Thromb (1992) 0.84
Nitrosylated high density lipoprotein is recognized by a scavenger receptor in rat liver. J Lipid Res (1989) 0.84
Characterization of the interaction of galactose-exposing particles with rat Kupffer cells. Biochem J (1994) 0.83
Kinetic evidence for the presence of two forms of M2-type pyruvate kinase in rat small intestine. Biochem Biophys Res Commun (1974) 0.83
Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles. Biochemistry (1994) 0.83
Visualization of the uptake and processing of oxidized low-density lipoproteins in human and rat liver. Hepatology (1993) 0.82
Properties of binding of lipases to non-parenchymal rat liver cells. Biochim Biophys Acta (1980) 0.82
Difference spectra, catalase- and peroxidase activities of isolated parenchymal and non-parenchymal cells from rat liver. Biochem Biophys Res Commun (1974) 0.82
Hormone-induced changes in pyruvate kinase activity in isolated hepatocytes. II. Relation to the hormonal regulation of gluconeogenesis. Biochim Biophys Acta (1977) 0.81
Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations. Clin Pharmacokinet (1996) 0.81